Abstract: A running exerciser assembly includes two side frames mounted in parallel with each other. Two plates each are horizontally formed on a top portion of a corresponding one of the two side frames, two L-shaped flange portions each are laterally formed on an upperside of a corresponding one of the two plates, and two cavities each are longitudinally defined between a corresponding one of the L-shaped flange portions and the associated plate and each face toward each other. Two recesses each are longitudinally defined in a bottom portion of a corresponding one of the two side plates and each include an opening facing toward each other. A supporting plate is mounted between the two side frees and includes two distal ends each securely fitted in a corresponding one of the two cavities. Two sliding posts each are slidably mounted in a corresponding one of the two recesses near a first end portion of the associated side free.

Abstract: An immuno-suppressor is described in the form of an immuno-suppressor serum and/or an IS-IgG extracted from this serum, produced by immunisation of an animal with antibody-covered cells; also described is the process for making said immuno-suppressor and its use for suppressing the humoral and/or cellular immune response.

Abstract: This application relates to a process for producing two glycoproteins of viral origin. More specifically, it relates to a process for producing in a substantially pure form Neuraminidase and Hemagglutinin from the cultures of Myxovirus Influenzae. These glycoproteins find a therapeutical use as a means for preventing or treating the flu.